Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Dose Finding Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. HIV seropositive diagnosed with standard techniques~2. Age for perinatally-acquired HIV/AIDS Group (PA subjects): 5.0 to 24.9 y~3. Age for non-perinatally-acquired HIV/AIDS Group (non-PA subjects): 15.0 to 24.9 y~4. In usual state of good health (no hospitalizations, emergency room or unscheduled acute illness visits for 2 weeks prior)~5. Subject and/or family commitment to the 3-month study~Exclusion Criteria:~1. Other chronic health conditions that may affect growth, dietary intake, and/or nutritional status~2. Pregnancy~3. Participation in another HIV intervention study with impact on 25D serum concentrations~4. Use of vit D supplementation (subjects willing to discontinue supplementation will become eligible after a 2-month washout period)~5. Baseline elevated serum calcium concentration~6. Non-English speaking

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 24 Years
- Healthy Volunteers: f

Study Arms:
- 4000IU (Type: ACTIVE_COMPARATOR): Subjects in this arm take a daily dose of 4000IU of Vitamin D3
- 7000IU (Type: ACTIVE_COMPARATOR): Subjects in this arm of the study take a daily dose of 7000IU of Vitamin D3

Based on this trial design, predict the completion outcome and termination type (if applicable).